Association of transcription factor 7-like 2 (TCF7L2) gene polymorphism with posttransplant diabetes mellitus in kidney transplant patients medicated with tacrolimus

Pharmacological Reports

Volumn 63, Issue 3, 2011, Pages 826-833

  Kurzawski, Mateusz ^a   Dziewanowski, Krzysztof ^b   Kȩdzierska, Karolina ^a   Wajda, Anna ^a   Lapczuk, Joanna ^a   Droździk, Marek ^a  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

^b Clinical Department of Nephrology and Dialysis   (Poland)

Author keywords

Genetic polymorphism; Posttransplant diabetes mellitus (PTDM); TCF7L2

Indexed keywords

GENOMIC DNA; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DOSE RESPONSE; DRUG DOSE REDUCTION; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC VARIABILITY; HAPLOTYPE; HIGH RISK PATIENT; HUMAN; KIDNEY GRAFT REJECTION; KIDNEY PANCREAS TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; RISK ASSESSMENT; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSCRIPTION FACTOR 7 LIKE 2 GENE;

EID: 80051515089     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/S1734-1140(11)70595-3     Document Type: Article

References (28)

1. Chakkera HA, Hanson RL, Raza SM, DiStefano JK, Millis MP, Heilman RL, Mulligan DC et al.: Pilot study: association of traditional and genetic risk factors and new-onset diabetes mellitus following kidney transplantation. Transplant Proc, 2009, 41, 4172-4177.
2. Davidson J, Wilkinson A, Dantal J, Dotta F, Haller H, Hernández D, Kasisike BL et al.: New-onset diabetes after transplantation: 2003 International consensus guidelines. Transplantation, 2003, 75, Suppl 10, SS3-SS24.
3. Ekstrand AV, Eriksson JG, Gronhagen-Riska C, Ahonen PJ, Groop LC: Insulin resistance and insulin deficiency in the pathogenesis of post-transplantation diabetes in man. Transplantation, 1992, 53, 563-569.
4. Ergün I, Keven K, Sengül S, Karabulut HG, Kurultak I, Soypacaci Z, Erbay B. Endothelial nitric oxide synthase gene intron 4 polymorphism predicts new onset diabetes mellitus after transplantation in kidney allograft recipients treated with cyclosporin A. Int Urol Nephrol, 2011, 43, 543-548.
5. Florez J, Jablonski KA, Bayley N, Pollin TI: TCF7L2 polymorphisms and progression to diabetes in the diabetes prevention program. N Engl J Med, 2006, 355, 241-250. (Pubitemid 44079339)
6. Gambino R, Bo S, Gentile L, Musso G, Pagano G, Cavallo-Perin P, Cassader M: Transcription factor 7-like 2 (TCF7L2) polymorphism and hyperglycemia in an adult Italian-population based cohort. Diabetes Care, 2010, 33, 1233-1235.
7. Ghisdal L, Baron C, Le Meur Y, Lionet A, Halimi JM, Rerolle JP, Glowacki F et al.: TCF7L2 polymorphism associates with new-onset diabetes after transplantation. J Am Soc Nephrol, 2009, 20, 2459-2467.
8. Grant SF, Thorleifsson G, Reynisdottir I, Benediktsson R, Manolescu A, Sainz J, Helgason A et al.: Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet, 2006, 38, 320-323.
9. Kahn SE: The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes. Diabetologia, 2003, 46, 3-19.
10. Kang ES, Kim MS, Kim YS, Hur KY, Han SJ, Nam CM, Ahn CW et al.: A variant of the transcription factor 7-like 2 (TCF7L2) gene and the risk of posttransplantation diabetes mellitus in renal allograft recipients. Diabetes Care, 2008, 31, 63-68.
11. Kasiske BL, Snyder JJ, Gilbertson D, Matas AJ: Diabetes mellitus after kidney transplantation in the United States. Am J Transplant, 2003, 3, 178-185. (Pubitemid 36323115)
12. Kimber CH, Doney AS, Pearson ER, McCarthy MI, Hattersley AT, Leese GP, Morris AD, Palmer CN: TCF7L2 in the Go-DARTS study: evidence for a gene dose effect on both diabetes susceptibility and control of glucose levels. Diabetologia, 2007, 50, 1186-1191. (Pubitemid 46701564)
13. Kumar MS, Heifets M, Moritz MJ, Saeed MI, Khan SM, Fyfe B, Sustento-Riodeca N et al.: Safety and efficacy of steroid withdrawal two days after kidney transplantation. Analysis of results at three years. Transplantation, 2006, 81, 832-839.
14. Markell M: New-onset diabetes mellitus in transplant patients: pathogenesis, complications, and management. Am J Kidney Dis, 2004, 43, 953-965.
15. Montori VM, Basu A, Erwin PJ, Velosa JA, Gabriel SE, Kudva YC: Posttransplantation diabetes: a systematic review of the literature. Diabetes Care, 2002, 25, 583-592.
16. Moore R, Ravindran V, Baboolal K: The burden of new-onset diabetes mellitus after transplantation. Clin Transplant, 2006, 20, 755-761. 13.
17. Musso G, Gambino R, Pacini G, Pagano G, Durazzo M, Cassader M: Transcription factor 7-like 2 polymorphism modulates glucose and lipid homeostasis, adipokine profile, and hepatocyte apoptosis in NASH. Hepatology, 2009, 49, 426-435.
18. Numakura K, Satoh S, Tsuchiya N, Horikawa Y, Inoue T, Kakinuma H, Matsuura S et al.: Clinical and genetic risk factors for posttransplant diabetes mellitus in adult renal transplant recipients treated with tacrolimus. Transplantation, 2005, 80, 1419-1424. (Pubitemid 41803623)
19. Papadopoulou S, Edlund H: Attenuated WNT signaling perturbs pancreatic growth but not pancreatic function. Diabetes, 2005, 54, 2844-2851. (Pubitemid 41401078)
20. Rodrigo E, Pińera C, de Cos MA, Sánchez B, Ruiz JC, Fernández-Fresnedo G, Palomar R et al.: Evolution of tacrolimus blood levels and concentration-dose ratios in patients who develop new onset diabetes mellitus after kidney transplantation. Transplant Int, 2005, 18, 1152-1157. (Pubitemid 41726759)
21. Sale MM, Smith SG, Mychaleckyj JC, Keene KL, Langefeld CD, Leak TS, Hicks PJ et al.: Variants of the transcription factor 7-like 2 (TCF7L2) gene are associated with type 2 diabetes in an African-American population enriched for nephropathy. Diabetes, 2007, 56, 2638-2642. (Pubitemid 47523273)
22. Schäfer SA, Tschritter O, Machicao F, Thamer C, Stefan N, Gallwitz B, Holst JJ et al.: Impaired glucagon-like peptide-1 (GLP-1)-induced insulin secretion in carriers of transcription factor 7-like 2 (TCF7L2) gene polymorphisms. Diabetologia, 2007, 50, 2443-2450. (Pubitemid 350060632)
23. Shah T, Kasravi A, Huang E, Hayashi R, Young B, Cho YW, Bunnapradist S: Risk factors for development of new-onset diabetes mellitus after transplantation. Transplantation, 2006, 82, 1673-1676. (Pubitemid 46035650)
24. Sulanc E, Lane JT, Puumala SE, Groggel GC, Wrenshall LE, Stevens RB: New-onset diabetes mellitus after kidney transplantation: an application of 2003 international guidelines. Transplantation, 2005, 80, 945-952. (Pubitemid 41552891)
25. Tabara Y, Osawa H, Kawamoto R, Onuma H, Shimizu I, Miki T, Kohara K, Makino H: Replication study of candidate genes associated with type 2 diabetes based on genome-wide screening. Diabetes, 2009, 58, 493-498.
26. van Hooff JP, Christiaans MH, van Duijnhoven EM: Tacrolimus and posttransplant diabetes mellitus in renal transplantation. Transplantation, 2005, 79, 1465-1469. (Pubitemid 40847574)
27. Vincenti F, Schena FP, Paraskevas S, Hauser IA, Walker RG, Grinyo J; FREEDOM Study Group: A randomized, multicenter study of steroid avoidance, early steroid withdrawal or standard steroid therapy in kidney transplant patients. Am J Transplant, 2008, 8, 307-316.
28. Weedon MN: The importance of TCF7L2. Diabet Med, 2007, 24, 1062-1066.